148 related articles for article (PubMed ID: 8285634)
1. Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.
Kar S; Kar K; Bhattacharya PK; Ghosh DK
Antimicrob Agents Chemother; 1993 Nov; 37(11):2459-65. PubMed ID: 8285634
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antileishmanial activity of trans-aconitic acid.
Misra S; Sanyal T; Sarkar D; Bhattacharya PK; Ghosh DK
Biochem Med Metab Biol; 1989 Dec; 42(3):171-8. PubMed ID: 2597432
[TBL] [Abstract][Full Text] [Related]
3. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.
Sodhi S; Kaur S; Mahajan RC; Ganguly NK; Malla N
Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():25-31. PubMed ID: 1322361
[TBL] [Abstract][Full Text] [Related]
4. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice.
Kuhlencord A; Maniera T; Eibl H; Unger C
Antimicrob Agents Chemother; 1992 Aug; 36(8):1630-4. PubMed ID: 1329624
[TBL] [Abstract][Full Text] [Related]
5. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.
Carter KC; Mullen AB; Sundar S; Kenney RT
Antimicrob Agents Chemother; 2001 Dec; 45(12):3555-9. PubMed ID: 11709339
[TBL] [Abstract][Full Text] [Related]
6. Leishmania donovani: amastigote inhibition and mode of action of berberine.
Ghosh AK; Bhattacharyya FK; Ghosh DK
Exp Parasitol; 1985 Dec; 60(3):404-13. PubMed ID: 4076392
[TBL] [Abstract][Full Text] [Related]
7. Potential of doxorubicin as an antileishmanial agent.
Sett R; Basu N; Ghosh AK; Das PK
J Parasitol; 1992 Apr; 78(2):350-4. PubMed ID: 1556650
[TBL] [Abstract][Full Text] [Related]
8. Sub-optimal dose of Sodium Antimony Gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-gamma to IL-10 ratio.
Haldar AK; Banerjee S; Naskar K; Kalita D; Islam NS; Roy S
Exp Parasitol; 2009 Jun; 122(2):145-54. PubMed ID: 19422069
[TBL] [Abstract][Full Text] [Related]
9. Activity of pentamidine-containing human red cell ghosts against visceral leishmaniasis in the hamster.
Berman JD; Gallalee JV; Williams JS; Hockmeyer WD
Am J Trop Med Hyg; 1986 Mar; 35(2):297-302. PubMed ID: 3953944
[TBL] [Abstract][Full Text] [Related]
10. Effect of ureastibamine on Leishmania donovani amastigote.
Ghosh AK; Mukerji K; Ghosh DK
Indian J Med Res; 1990 May; 91():208-13. PubMed ID: 2397943
[TBL] [Abstract][Full Text] [Related]
11. Visceral leishmaniasis: resistance to reinfection in the liver following chemotherapy in the BALB/c mouse.
Carter KC; Alexander J; Baillie AJ; Dolan TF
Exp Parasitol; 1989 May; 68(4):375-81. PubMed ID: 2542078
[TBL] [Abstract][Full Text] [Related]
12. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.
Dube A; Singh N; Sundar S; Singh N
Parasitol Res; 2005 Jun; 96(4):216-23. PubMed ID: 15868188
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural study on the antileishmanial effect of 1,2-dimethyl-3-methoxy carbonyl-4-(2-nitro-4,5-dimethoxyphenyl) pyrrole in hamsters.
Bhatnagar S; Maitra SC; Guru PY; Katiyar JC
Indian J Med Res; 1991 May; 93():147-51. PubMed ID: 1657768
[TBL] [Abstract][Full Text] [Related]
14. Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani.
Chen M; Christensen SB; Theander TG; Kharazmi A
Antimicrob Agents Chemother; 1994 Jun; 38(6):1339-44. PubMed ID: 8092835
[TBL] [Abstract][Full Text] [Related]
15. Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis.
Chakrabarti G; Basu A; Manna PP; Mahato SB; Mandal NB; Bandyopadhyay S
J Antimicrob Chemother; 1999 Mar; 43(3):359-66. PubMed ID: 10223591
[TBL] [Abstract][Full Text] [Related]
16. Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.
Chunge CN; Gachihi G; Muigai R; Wasunna K; Rashid JR; Chulay JD; Anabwani G; Oster CN; Bryceson AD
Trans R Soc Trop Med Hyg; 1985; 79(5):715-8. PubMed ID: 3006296
[TBL] [Abstract][Full Text] [Related]
17. Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate.
Collins M; Carter KC; Baillie AJ
Ann Trop Med Parasitol; 1992 Feb; 86(1):35-40. PubMed ID: 1319700
[TBL] [Abstract][Full Text] [Related]
18. Action of p-(4-amidino-phenoxy)-benzaldehyde-p-amidino-phenylhydrazone dihydrochloride on Leishmania donovani infections in the golden hamster.
Raether W; Seidenath H; Loewe H
Ann Trop Med Parasitol; 1978 Dec; 72(6):543-7. PubMed ID: 216324
[TBL] [Abstract][Full Text] [Related]
19. Activity of purine analogs against Leishmania donovani in vivo.
Berman JD; Hanson WL; Lovelace JK; Waits VB; Jackson JE; Chapman WL; Klein RS
Antimicrob Agents Chemother; 1987 Jan; 31(1):111-3. PubMed ID: 3566235
[TBL] [Abstract][Full Text] [Related]
20. Problems in the treatment of kala-azar: case report.
Nyakundi PM; Rashid JR; Wasunna KM; Were JB; Muigai R; Kirigi G; Mbugua J
East Afr Med J; 1995 Jun; 72(6):406-8. PubMed ID: 7498017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
